TEVA compared with AMRX: revenue, margins and what each company keeps, and the suppliers and customers both name

TEVATeva Pharmaceutical Industries Ltd

Mkt capRevenueRevenue

AMRXAmneal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

TEVATeva Pharmaceutical Industries Ltd

AMRXAmneal Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TEVA

Reportimpliedrealized× implied

Q2 FY26—▲+9.60%—

Q1 FY26—▲+11.89%—

Jan 28 '26—▲+2.09%—

Jan 12 '26—▲+2.44%—

AMRX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.6%▼−3.14%×0.20

May 8 '26±10.1%▼−3.79%×0.38

= impliedTEVA realized, solidAMRX realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

Q1 FY26

±21.3%

▼−1.54%

×0.07

Feb 27 '26±12.6%▼−4.69%×0.37

TEVATeva Pharmaceutical Industries Ltd

42.09▲+1.50%· post 41.97

Mkt cap$49.0BRevenue$4.1BQ2 FY26Revenue$17.3BFY25

AMRXAmneal Pharmaceuticals, Inc.

21.50▲+0.70%· post 21.43

ClosedOct 30 '26

Mkt cap$6.9BRevenue$796MQ2 FY26Revenue$3.0BFY25

Compare

ClosedOct 30 '26

TEVATeva Pharmaceutical Industries Ltd

AMRXAmneal Pharmaceuticals, Inc.

42.09▲+1.50%post 41.97

Price

21.50▲+0.70%post 21.43

$49.0B

Mkt cap

$6.9B

Q2 FY26$4.1B

Revenue

$796MQ2 FY26

FY25$17.3B

Revenue

$3.0BFY25

TEVA42.09▲+1.50%vsAMRX21.50▲+0.70%ClosedOct 30 '26